Chemical Structure : BML-277
CAS No.: 516480-79-8
货号: PC-49284Not For Human Use, Lab Use Only.
BML-277 (BML277) is a potent, selective and ATP-competitive inhibitor of Chk2 serine/threonine kinase with IC50 of 15 nM, >1000-fold selectivity over Chk1 and Cdk1/B kinases.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥780 | In stock | |
25 mg | ¥1180 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥3280 | In stock | |
200 mg | Get quote | ||
1 g | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BML-277 (BML277) is a potent, selective and ATP-competitive inhibitor of Chk2 serine/threonine kinase with IC50 of 15 nM, >1000-fold selectivity over Chk1 and Cdk1/B kinases.
BML-277 dose dependently protects human CD4+ and CD8+ T-cells from apoptosis due to ionizing radiation.
BML-277 specifically inhibit CHK2 phosphorylation at Thr68 at different time course, but not CHK1 phosphorylation.
BML-277 significantly promoted pneumonia symptoms, including mortality, lung infiltration of immune cells, and the abundance of lung pro-inflammatory cytokines in vivo.
BML-277 reduced protein poly(ADP-ribosyl)ation (PARylation), FANCD2 monoubiquitination, homologous recombination and OR CRC cell growth in vitro and in vivo.
分子量 | 363.80 | |
分子式 | C20H14ClN3O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-[4-(4-Chlorophenoxy)phenyl]-1H-benzimidazole-6-carboxamide |
1. Kristen L Arienti, et al. J Med Chem. 2005 Mar 24;48(6):1873-85.
2. Xie F, et al. Exp Lung Res. 2022 Jan 25:1-8.
3. Hsieh CC, et al. Br J Cancer. 2022 Aug 23. doi: 10.1038/s41416-022-01946-9.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright